These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 32334775)

  • 1. Authors' Response to Association between Acetylcholinesterase Inhibitors and Osteoporotic Fractures in Older Persons With Alzheimer's Disease.
    Kim JH; Byun SJ; Shin JY
    J Am Med Dir Assoc; 2020 May; 21(5):707. PubMed ID: 32334775
    [No Abstract]   [Full Text] [Related]  

  • 2. Comment on "Association Between Acetylcholinesterase Inhibitors and Osteoporotic Fractures in Alzheimer's Patients".
    Naharci MI; Tasci I
    J Am Med Dir Assoc; 2020 May; 21(5):706-707. PubMed ID: 32334774
    [No Abstract]   [Full Text] [Related]  

  • 3. Association Between Acetylcholinesterase Inhibitors and Osteoporotic Fractures in Older Persons With Alzheimer's Disease.
    Won DY; Byun SJ; Jeong JS; Shin JY
    J Am Med Dir Assoc; 2020 Aug; 21(8):1128-1133.e1. PubMed ID: 31926798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acetylcholinesterase inhibitors and the risk of osteoporotic fractures: nested case-control study.
    Tamimi I; Nicolau B; Eimar H; Arekunnath Madathil S; Kezouh A; Karp I; Tamimi F
    Osteoporos Int; 2018 Apr; 29(4):849-857. PubMed ID: 29264626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacodynamic-tolerability relationships of cholinesterase inhibitors for Alzheimer's disease.
    Imbimbo BP
    CNS Drugs; 2001; 15(5):375-90. PubMed ID: 11475943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term thiazide use and risk of low-energy fractures among persons with Alzheimer's disease-nested case-control study.
    Taipale H; Rysä J; Hukkanen J; Koponen M; Tanskanen A; Tiihonen J; Kröger H; Hartikainen S; Tolppanen AM
    Osteoporos Int; 2019 Jul; 30(7):1481-1489. PubMed ID: 30993395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between Pisa syndrome and cholinesterase inhibitor use for elderly adults with Alzheimer's disease.
    Huvent-Grelle D; Boulanger E; Puisieux F
    J Am Geriatr Soc; 2014 Dec; 62(12):2450-3. PubMed ID: 25516048
    [No Abstract]   [Full Text] [Related]  

  • 8. Use of antidementia drugs and risk of pneumonia in older persons with Alzheimer's disease.
    Lampela P; Tolppanen AM; Tanskanen A; Tiihonen J; Lavikainen P; Hartikainen S; Taipale H
    Ann Med; 2017 May; 49(3):230-239. PubMed ID: 27786552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Collapse in the elderly: rivastigmine-induced heart block and a literature review of the pharmacology of acetylcholinesterase inhibitors used in Alzheimer's disease.
    Alonge O; Iqbal FM; Cifonelli E
    BMJ Case Rep; 2018 Apr; 2018():. PubMed ID: 29666099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholinesterase inhibitors used in the treatment of Alzheimer's disease: the relationship between pharmacological effects and clinical efficacy.
    Wilkinson DG; Francis PT; Schwam E; Payne-Parrish J
    Drugs Aging; 2004; 21(7):453-78. PubMed ID: 15132713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Observations on the physostigmine syndrome in patients with Alzheimer's disease.
    Wirkowski E; Prohovnik I; Young WL
    J Neuropsychiatry Clin Neurosci; 1991; 3(1):73-5. PubMed ID: 7580177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. When should one stop cholinesterase inhibitors in patients with Alzheimer's disease?
    Bogardus ST
    J Psychiatry Neurosci; 2001 Nov; 26(5):425. PubMed ID: 11762210
    [No Abstract]   [Full Text] [Related]  

  • 13. [Should Alzheimer disease be treated with tacrine? Review of the literature].
    Arsland D; Laake K
    Tidsskr Nor Laegeforen; 1996 Sep; 116(23):2791-4. PubMed ID: 8928167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of Cholinesterase Inhibitors Increases Initiation of Urinary Anticholinergics in Persons with Alzheimer's Disease.
    Lampela P; Taipale H; Hartikainen S
    J Am Geriatr Soc; 2016 Jul; 64(7):1510-2. PubMed ID: 27401848
    [No Abstract]   [Full Text] [Related]  

  • 15. Cholinesterase inhibitors for the treatment of Alzheimer's disease in the elderly.
    VanDenBerg CM; Kazmi Y; Jann MW
    Drugs Aging; 2000 Feb; 16(2):123-38. PubMed ID: 10755328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Alzheimer dementia].
    Hock C; Nitsch RM
    Praxis (Bern 1994); 2000 Mar; 89(13):529-40. PubMed ID: 10776055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholinesterase inhibitor treatment and urinary incontinence in Alzheimer's disease.
    Starr JM
    J Am Geriatr Soc; 2007 May; 55(5):800-1. PubMed ID: 17493206
    [No Abstract]   [Full Text] [Related]  

  • 18. Risk of antipsychotic drug use in patients with Alzheimer's disease treated with rivastigmine.
    Suh DC; Arcona S; Thomas SK; Powers C; Rabinowicz AL; Shin H; Mirski D
    Drugs Aging; 2004; 21(6):395-403. PubMed ID: 15084141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Citicholinage Study: Citicoline Plus Cholinesterase Inhibitors in Aged Patients Affected with Alzheimer's Disease Study.
    Gareri P; Castagna A; Cotroneo AM; Putignano D; Conforti R; Santamaria F; Marino S; Putignano S
    J Alzheimers Dis; 2017; 56(2):557-565. PubMed ID: 28035929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The application of evidence-based principles of care in older persons (issue 5): Alzheimer's disease.
    Zarowitz BJ; Stefanacci R; Hollenack K; O'Shea T; Gruber J; Tangalos EG
    J Am Med Dir Assoc; 2007 Mar; 8(3):183-93. PubMed ID: 17349948
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.